HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John A Heit Selected Research

Hemorrhage

11/2015Thrombin generation and procoagulant microparticle profiles after acute trauma: A prospective cohort study.
8/2014Rethinking guidelines for VTE risk among nursing home residents: a population-based study merging medical record detail with standardized nursing home assessments.
6/2014Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study.
1/2013Three-month cumulative incidence of thromboembolism and bleeding after periprocedural anticoagulation management of arterial vascular bypass patients.
2/2012Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
3/2011Evaluation of a screening tool for bleeding disorders in a US multisite cohort of women with menorrhagia.
3/2010Periprocedural anticoagulation management of patients with venous thromboembolism.
1/2010Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition).
12/2009Warfarin sensitivity genotyping: a review of the literature and summary of patient experience.
7/2009Peri-procedural anticoagulation management of mechanical prosthetic heart valve patients.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John A Heit Research Topics

Disease

26Venous Thromboembolism
07/2018 - 06/2002
20Neoplasms (Cancer)
01/2018 - 06/2002
18Thrombosis (Thrombus)
01/2018 - 01/2002
16Wounds and Injuries (Trauma)
01/2018 - 06/2002
12Paresis (Hemiparesis)
01/2018 - 06/2002
12Hemorrhage
11/2015 - 06/2008
7Thromboembolism
01/2013 - 04/2004
5Heart Failure
01/2018 - 06/2002
5Thrombophilia
01/2014 - 01/2004
5Pulmonary Embolism
11/2011 - 08/2002
4Infections
01/2018 - 07/2010
4Stroke (Strokes)
06/2015 - 06/2008
4Cardiovascular Diseases (Cardiovascular Disease)
01/2013 - 07/2005
4Venous Thrombosis (Deep-Vein Thrombosis)
11/2011 - 08/2002
3Menorrhagia
12/2017 - 04/2009
3Obesity
01/2017 - 11/2013
3Alcoholism (Alcohol Abuse)
10/2015 - 06/2013
3Varicose Veins (Varicose Vein)
06/2015 - 06/2002
3Atrial Fibrillation
01/2013 - 06/2008
3Pain (Aches)
10/2010 - 01/2010
2Diabetes Mellitus
01/2018 - 09/2009
2Vascular Remodeling
01/2016 - 01/2014
2Myocardial Infarction
06/2015 - 09/2006
2Acute Coronary Syndrome
09/2013 - 08/2002
2Postthrombotic Syndrome
10/2010 - 08/2002
1COVID-19
01/2022
1Intracranial Sinus Thrombosis (Sinus Thrombosis)
01/2022
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2018
1Asthma (Bronchial Asthma)
01/2018
1Liver Diseases (Liver Disease)
01/2018
1Neoplasm Metastasis (Metastasis)
03/2016
1Substance-Related Disorders (Drug Abuse)
10/2015
1Peripheral Vascular Diseases (Peripheral Vascular Disease)
06/2015
1Ovarian Neoplasms (Ovarian Cancer)
06/2014
1Pancreatic Neoplasms (Pancreatic Cancer)
06/2014
1Gangrene
06/2014
1Hyperemia
01/2014
1Coronary Artery Disease (Coronary Atherosclerosis)
06/2012
1Hyperhomocysteinemia
05/2012
1Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
05/2012
1Protein S Deficiency (Deficiency, Protein S)
05/2012
1Hemostatic Disorders
03/2011
1von Willebrand Diseases (von Willebrand's Disease)
12/2010
1Mouth Neoplasms (Oral Cancer)
11/2010
1Arthritis (Polyarthritis)
10/2010

Drug/Important Bio-Agent (IBA)

10AnticoagulantsIBA
06/2014 - 12/2002
8Warfarin (Coumadin)FDA LinkGeneric
08/2015 - 07/2009
7Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
01/2013 - 09/2004
6Hormones (Hormone)IBA
01/2018 - 02/2006
6Heparin (Liquaemin)FDA LinkGeneric
05/2012 - 06/2008
5Estrogens (Estrogen)FDA Link
12/2017 - 09/2006
4AntithrombinsIBA
12/2017 - 09/2003
4ThrombinFDA Link
01/2017 - 06/2012
3mahuang-tangIBA
01/2016 - 01/2013
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
08/2015 - 06/2008
3factor V LeidenIBA
01/2014 - 01/2002
3fibrin fragment D (D-dimer)IBA
05/2012 - 02/2004
3Protein CIBA
05/2012 - 04/2005
3FibrinIBA
05/2012 - 02/2004
3Oral ContraceptivesIBA
11/2010 - 06/2002
2DNA (Deoxyribonucleic Acid)IBA
01/2017 - 05/2012
2preproenkephalinIBA
10/2015 - 06/2013
2thiamine triphosphorate (TTP)IBA
07/2010 - 10/2009
2Prothrombin (Factor II)IBA
07/2010 - 01/2002
2LatexIBA
05/2007 - 02/2004
1Ad26COVS1IBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2017
1ProgesteroneFDA LinkGeneric
03/2016
1ORALIT (ORS)IBA
09/2015
1LipidsIBA
06/2015
1RivaroxabanIBA
06/2014
1Acamprosate (Campral)FDA Link
03/2014
1Adenosine Triphosphate (ATP)IBA
01/2014
1ProstaglandinsIBA
01/2014
1GlucocorticoidsIBA
07/2013
1Opioid Receptors (Opioid Receptor)IBA
06/2013
1Pharmaceutical PreparationsIBA
06/2013
1Glycine (Aminoacetic Acid)FDA LinkGeneric
03/2012
1Endothelial Protein C ReceptorIBA
03/2012
1Codon (Codons)IBA
03/2012
1Serine (L-Serine)FDA Link
03/2012
1CalciumIBA
12/2011
1Ferritins (Ferritin)IBA
03/2011
1Hemostatics (Antihemorrhagics)IBA
03/2011
1von Willebrand FactorIBA
12/2010
1Contraceptive Agents (Contraceptives)IBA
11/2010
1Progestins (Progestagens)IBA
11/2010

Therapy/Procedure

19Therapeutics
01/2018 - 08/2002
15Home Nursing (Nursing, Home)
07/2018 - 06/2002
6Central Venous Catheters
08/2015 - 06/2002
3Catheters
01/2018 - 01/2010
3Contraception (Birth Control)
12/2017 - 08/2015
3Thrombolytic Therapy
01/2010 - 09/2004
2Length of Stay
01/2017 - 11/2015
2Drug Therapy (Chemotherapy)
03/2016 - 07/2010
1General Anesthesia
01/2017
1Aftercare (After-Treatment)
10/2015
1Gastric Bypass (Roux-en-Y Gastric Bypass)
11/2013
1Bariatric Surgery
11/2013
1Injections
11/2010